Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Dianthus Therapeutics, Inc. insider trades

Dianthus Therapeutics, Inc.'s insiders made 0 buys and 49 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Sep 17, 2026Carr EdwardSale700US$104Form 4
Sep 17, 2026Carr EdwardSale7,928US$100Form 4
Sep 17, 2026Carr EdwardSale1,100US$103Form 4
Sep 17, 2026Carr EdwardSale6,771US$101Form 4
Sep 17, 2026Carr EdwardSale3,501US$102Form 4
Sep 1, 2026Randhawa SimratSale7,215US$106Form 4
Sep 1, 2026Randhawa SimratSale2,600US$105Form 4
Sep 1, 2026Randhawa SimratSale13,309US$107Form 4
Aug 19, 2026Read SimonSale2,778US$118Form 4
Aug 10, 2026McGeorge AnneSale1,000US$111Form 4

Dianthus Therapeutics, Inc. shareholders